Cargando…

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

BACKGROUND: Reports on soluble interleukin‐6 (IL‐6) receptor (sIL‐6R) and glycoprotein 130 (sgp130) in ST‐elevation myocardial infarction (STEMI) are few and include a small number of patients. The aim of this study was to investigate the possible association between levels of these biomarkers in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritschel, Vibeke N., Seljeflot, Ingebjørg, Arnesen, Harald, Halvorsen, Sigrun, Eritsland, Jan, Fagerland, Morten W., Andersen, Geir Ø.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937252/ https://www.ncbi.nlm.nih.gov/pubmed/27412895 http://dx.doi.org/10.1161/JAHA.115.003014

Ejemplares similares

Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
por: Hansen, Charlotte Holst, et al.
Publicado: (2018)

Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
por: Ritschel, Vibeke, et al.
Publicado: (2017)

Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
por: Helseth, Ragnhild, et al.
Publicado: (2019)

Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure
por: Husebye, Trygve, et al.
Publicado: (2014)

Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
por: Knudsen, Eva C, et al.
Publicado: (2009)

IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
por: Knudsen, Eva Cecilie, et al.
Publicado: (2019)

Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
por: Hansen, C. H., et al.
Publicado: (2015)

Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
por: Knudsen, Eva C, et al.
Publicado: (2011)

Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
por: Shetelig, Christian, et al.
Publicado: (2017)

Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
por: Kvakkestad, Kristin Marie, et al.
Publicado: (2017)

The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
por: Helseth, Ragnhild, et al.
Publicado: (2014)

Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
por: Helseth, Ragnhild, et al.
Publicado: (2019)

The Influence of Autologous Bone Marrow Stem Cell Transplantation on Matrix Metalloproteinases in Patients Treated for Acute ST-Elevation Myocardial Infarction
por: Furenes, Eline Bredal, et al.
Publicado: (2014)

Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
por: Knudsen, Eva C, et al.
Publicado: (2010)

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
por: Tøllefsen, Ingvild Maria, et al.
Publicado: (2021)

Effect of Ischemic Postconditioning on Infarct Size in Patients With ST‐Elevation Myocardial Infarction Treated by Primary PCI Results of the POSTEMI (POstconditioning in ST‐Elevation Myocardial Infarction) Randomized Trial
por: Limalanathan, Shanmuganathan, et al.
Publicado: (2014)

Effects on Serum Fractalkine by Diet and Omega-3 Fatty Acid Intervention: Relation to Clinical Outcome
por: Laake, Kristian, et al.
Publicado: (2015)

Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
por: Claussen, Peter Andreas, et al.
Publicado: (2014)

Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
por: Solheim, Svein, et al.
Publicado: (2013)

Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study
por: Opstad, Trine B, et al.
Publicado: (2011)

Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
por: Chiva-Blanch, Gemma, et al.
Publicado: (2017)

The Co-Existence of the IL-18+183 A/G and MMP-9 -1562 C/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients
por: Opstad, Trine B., et al.
Publicado: (2013)

The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
por: Helseth, Ragnhild, et al.
Publicado: (2016)

The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
por: Helseth, Ragnhild, et al.
Publicado: (2015)

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012)

The role of interleukin-18 in the metabolic syndrome
por: Trøseid, Marius, et al.
Publicado: (2010)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023)

Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
por: Seljeflot, Ingebjorg, et al.
Publicado: (2012)

Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
por: Arnesen, Harald, et al.
Publicado: (2020)

A brief review on resistance to P2Y(12) receptor antagonism in coronary artery disease
por: Warlo, Ellen M. K., et al.
Publicado: (2019)

von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
por: Warlo, Ellen M.K., et al.
Publicado: (2023)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021)

Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
por: Laake, Kristian, et al.
Publicado: (2016)

Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction
por: Nilsen, Dennis Winston T., et al.
Publicado: (2021)

The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer
por: Martínez-Pérez, Carlos, et al.
Publicado: (2021)

Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia
por: Trøseid, Marius, et al.
Publicado: (2009)

Roles of IL-6-gp130 Signaling in Vascular Inflammation
por: Hou, Tieying, et al.
Publicado: (2008)

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis
por: Schwerd, Tobias, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2r5vaj93df8sulgimm32bjk2ac